Status:
UNKNOWN
Assessment of Skeletal Muscle Dysfunction in Patient With Idiopathic Pulmonary Fibrosis
Lead Sponsor:
Assiut University
Conditions:
Interstitial Lung Disease
Skeletal Muscle Dysfunction
Eligibility:
All Genders
Phase:
NA
Brief Summary
Interstitial lung disease includes a heterogeneous group of chronic lung conditions that is characterized by exertional dyspnoea and poor health related quality of life . includes idiopathic pulmonary...
Detailed Description
Interstitial lung disease includes a heterogeneous group of chronic lung conditions that is characterized by exertional dyspnoea and poor health related quality of life . includes idiopathic pulmonary...
Eligibility Criteria
Inclusion
- All patient who will be presented to assuit chest department and diagnosed as IPF.
Exclusion
- 1-IPF patient with malignant tumors. 2-Comorbid end stage renal, cardiac or hepatic patient. 3-patient who refused to participate in the study
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03440489
Start Date
July 1 2018
End Date
July 1 2020
Last Update
February 22 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.